Pfizer Inc (NYSE:PFE)
| 39.22 Delayed Data As of 5:43pm ET |  +0.17 / +0.44%Today’s Change | 29.96 Today|||52-Week Range 43.08 | +6.55% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $217.2B |
Company Description
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.Contact Information
Pfizer Inc. 235 East 42nd Street New York New York 10017-5755 |
Employees
Shareholders
| Mutual fund holders | 36.07% |
| Other institutional | 30.41% |
| Individual stakeholders | 0.29% |
Top Executives
| Albert Bourla | Chairman, Chief Executive & Operating Officer |
| Frank A. D'Amelio | Chief Financial Officer & EVP-Global Supply |
| Mikael Dolsten | Chief Scientific Officer & Research President |
| Aida Habtezion | Chief Medical Officer |
| Lidia L. Fonseca | Executive VP, Chief Digital & Technology Officer |
